Carvedilol API Manufacturing and Quality Parameters: A Buyer’s Guide for Cardiovascular Formulators

Carvedilol API is a racemic, poorly water-soluble beta-blocker made by multi-step synthesis. The parameters that matter to a formulator are assay, related substances, residual solvents, crystalline form and particle size, because carvedilol is a BCS Class II drug whose dissolution depends on the solid you receive. Ask for the pharmacopoeial grade in writing, the batch Certificate of Analysis, and the site’s GMP and ISO documents before the first purchase order.

How Carvedilol API Is Made

Carvedilol is (2RS)-1-(9H-carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]propan-2-ol, CAS 72956-09-3, molecular formula C24H26N2O4, molecular weight 406.47 g/mol. The published route joins two halves: a carbazole bearing an epoxide on the 4-position oxygen, and 2-(2-methoxyphenoxy)ethylamine. Opening the epoxide with the amine builds the propanolamine chain that gives the molecule its beta-blocking pharmacophore. The crude product is then purified by crystallisation and dried.

Two things in that step matter to a buyer. The epoxide is reactive, and any that survives the coupling appears in the finished API as a specified impurity. The amine can also react with two epoxide molecules instead of one, giving the bis-adduct that the pharmacopoeial monographs and published HPLC method papers describe. Stoichiometry, temperature and work-up in the coupling step decide how much of each the plant has to remove later.

Bio-Synth has made APIs at its Balanagar site in Hyderabad since 1943, and Carvedilol API is one of the products on its list. Carvedilol intermediates are made in-house. A general outline of how a small-molecule API moves from starting material to release is in the post on the API manufacturing process overview.

The Quality Parameters That Decide a Batch

A Certificate of Analysis for Carvedilol API lists the tests in the monograph for the grade supplied. These are the ones that matter most to a formulator.

Assay. The USP method is HPLC; the IP method is potentiometric titration. The published limits are 98.0% to 102.0% w/w on the dried substance for the USP grade and 99.0% to 101.0% for the IP grade. Read the method as well as the number. A titration measures the basic amine and will not distinguish carvedilol from a basic impurity; HPLC will.

Related substances. The published limits are not more than 0.5% total impurities for both grades, with any single unspecified impurity not more than 0.1% (USP) or 0.2% (IP). ICH Q3A sets the reporting, identification and qualification thresholds behind those numbers. For a drug dosed well under 2 g per day, ICH Q3A puts the identification threshold at 0.10% and the qualification threshold at 0.15%, which is why a CoA that only reports “total” is not enough. Ask for the individual impurity results by retention time.

Residual solvents. Carvedilol is crystallised from organic solvent, so ICH Q3C Class 2 and Class 3 solvent limits apply. The CoA should name the solvents tested, not just report “complies”.

Loss on drying. Assay is expressed on the dried substance, so the drying value changes the effective potency of what you weigh.

Appearance and identification. White or almost white crystalline powder, identified by IR against a reference standard. Identification confirms the molecule. It does not confirm the polymorph, which is the next parameter.

Crystalline Form, Particle Size and Solubility

Carvedilol is practically insoluble in water and is classified as a BCS Class II drug in the published dissolution literature: low solubility, high permeability, with solubility that rises as pH falls because the secondary amine protonates. Dissolution of an immediate-release tablet therefore depends on the solid-state properties of the API as much as on its purity.

Two properties carry that load. The first is polymorphic form: crystallographic studies report several crystalline forms of carvedilol with different dissolution behaviour, so a tablet developed on one form and then made with another will show a dissolution shift with no change in assay. The second is particle size distribution. For a poorly soluble drug, surface area drives dissolution rate, and a d90 that drifts between lots shows up in the dissolution profile first.

Neither property is a standard monograph test, so both have to be agreed as additional specifications. Ask the site which crystalline form it supplies and whether it tests each batch by XRPD, and ask whether a particle size specification or a micronised grade is available. 

Grades: IP, BP and USP

Bio-Synth offers BP, USP and IP grades of Carvedilol API, with separate storage instructions for each. The USP grade is preserved in a tight container at controlled room temperature. The IP grade is stored protected from light at a temperature not exceeding 30 °C. Certificates of Analysis for IP, BP and USP grades are on file. 

The grade you order should match the market you file in. The monographs differ in method and in impurity lists, and a CoA issued against one cannot be read across to another. Fix the grade in the specification before the purchase order, and ask that the CoA state it.

What Sits Behind the Certificate of Analysis

ICH Q7 is the GMP standard for APIs. It requires defined critical process steps, in-process controls, validated cleaning between products, change control, and a batch record for every lot. Bio-Synth’s API operations run in line with ICH Q7 principles. That is a company declaration, not a third-party certificate, and it should be read as one.

The site’s quality management system is certified to ISO 9001:2015 by DNV Business Assurance under UKAS accreditation, certificate 156792-2014-AQ-IND-UKAS, first certified in August 2002. The scope on the certificate reads “Development, manufacture and sale of active pharmaceutical ingredients (APIs), drug intermediates, biological products & liver injectable”. That is a facility-level management system certificate. It says nothing about any single product. 

The Balanagar site also holds a WHO-GMP certificate from the Drugs Control Administration, Government of Telangana, valid until June 2027, issued under the export scheme for the products named in its joint inspection report. Those products are Amino Salicylate Sodium USP and Sodium Amino Salicylate Dihydrate BP/Ph.Eur. Carvedilol is not on that schedule as the certificate stands, and a buyer should not treat it as WHO-GMP certified until it is. How the site’s systems fit together is described on the quality page.

What to Ask For Before the First Order

Ask for the grade in writing. Ask for a CoA from a recent batch with individual impurities and named residual solvents. Ask which crystalline form is supplied and how it is confirmed. Ask for a sample large enough to run your own assay, related substances and dissolution. Ask for the ISO 9001:2015 certificate, the GMP declaration and the current WHO-GMP product schedule, and read each at its own scope. A source that answers with documents rather than assurances is telling you how its quality unit works. The clinical background to the molecule is in the companion posts on what Carvedilol API is and its uses and on the Carvedilol mechanism of action.

Frequently Asked Questions

Which impurities matter most in Carvedilol API?

The process impurities described in the pharmacopoeial monographs and published method papers are the carbazole epoxide starting material and the bis-adduct formed when the amine reacts with two epoxide molecules. Both are controlled by the coupling and purification steps, and both should appear as individual results on the CoA.

Is a chiral purity test required for Carvedilol API?

The pharmacopoeial monographs describe carvedilol as the racemate, (2RS), and the API is supplied and dosed as the racemate. A chiral purity test is not a standard monograph requirement. If your formulation or filing needs one, agree upfront it as an additional specification.

Why does the crystalline form of Carvedilol matter if the assay is correct?

Carvedilol is practically insoluble in water and dissolution of the tablet depends on the solid form. Different crystalline forms dissolve at different rates, so a change in form can shift a dissolution profile with no change in assay or purity.

What is the difference between the USP and IP assay for Carvedilol?

The USP assay is by HPLC with limits of 98.0% to 102.0% on the dried substance. The IP assay is by potentiometric titration with limits of 99.0% to 101.0%. The methods measure different things, so the two numbers are not directly comparable.

Does a WHO-GMP certificate cover every API a site makes?

No. A WHO-GMP certificate issued under the export scheme names the products covered in its inspection report. Ask for the product schedule and check that the API you are buying is on it.

How should Carvedilol API be stored?

The USP grade is preserved in a tight container at controlled room temperature. The IP grade is stored protected from light at a temperature not exceeding 30 °C. Follow the storage instruction for the grade on your CoA.